» Articles » PMID: 2456467

Cytotoxic T Cells Specific for the Circumsporozoite Protein of Plasmodium Falciparum

Overview
Journal Nature
Specialty Science
Date 1988 Jul 21
PMID 2456467
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Malaria is initiated by the inoculation of a susceptible host with sporozoites from an infected mosquito. The sporozoites enter hepatocytes and develop for a period as exoerythrocyte or hepatic stage parasites. Vaccination with irradiated sporozoites can provide protective immunity and a recent study shows that this can also be conferred by immunization with a recombinant salmonella expressing only the circumsporozoite protein that normally covers the sporozoites. Protection against infection is likely to be mediated by cytotoxic CD8+ cells, as depletion of CD8+ T cells in a sporozoite-immunized animal can completely abrogate immunity. Here we demonstrate directly the existence of CD8+ cytotoxic T lymphocytes (CTL) that recognize the circumsporozoite protein. B10.BR mice immunized with sporozoites or with recombinant vaccinia virus expressing the CS protein of Plasmodium falciparum contain CTL that specifically kill L cell fibroblasts transfected with the gene encoding the same CS protein. The peptide epitope from the CS protein that is recognized by CTL from this strain of mice is from a variant region of the protein.

Citing Articles

A multivalent circumsporozoite protein-based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats.

Pendyala G, Calvo-Calle J, Moreno A, Kane R Bioeng Transl Med. 2023; 8(4):e10514.

PMID: 37476056 PMC: 10354751. DOI: 10.1002/btm2.10514.


Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites.

Markwalter C, Petersen J, Zeno E, Sumner K, Freedman E, Mangeni J PLoS Pathog. 2023; 19(6):e1011442.

PMID: 37307293 PMC: 10289385. DOI: 10.1371/journal.ppat.1011442.


Symptomatic malaria enhances protection from reinfection with homologous parasites.

Markwalter C, Petersen J, Zeno E, Sumner K, Freedman E, Mangeni J medRxiv. 2023; .

PMID: 36711685 PMC: 9882554. DOI: 10.1101/2023.01.04.23284198.


Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages.

Huang W, Mabrouk M, Zhou L, Baba M, Tachibana M, Torii M Commun Biol. 2022; 5(1):773.

PMID: 35915227 PMC: 9341416. DOI: 10.1038/s42003-022-03688-z.


Robust antibody and CD8 T-cell responses induced by CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.

Espinosa D, Christensen D, Munoz C, Singh S, Locke E, Andersen P NPJ Vaccines. 2017; 2.

PMID: 28936360 PMC: 5603302. DOI: 10.1038/s41541-017-0011-y.